Rick Suarez Named Head of AstraZeneca's US Biopharma Business Amid USD 50 Billion Expansion Plan sheeba farhat12 Jan 2026 7:16 PM ISTBengaluru: AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmaker's USD...
Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution Farhat Nasim8 Jan 2026 6:08 PM ISTOlopatadine Hydrochloride Ophthalmic Solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis, a common...
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules' Generic Amphetamine XR Farhat Nasim8 Jan 2026 3:11 PM ISTHyderabad: Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, has received tentative approval (TA) from the U.S....
Cipla Partner Pharmathen Receives 9 USFDA Observations Farhat Nasim7 Jan 2026 8:22 PM ISTCipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.
Novo Nordisk's US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle sheeba farhat7 Jan 2026 4:04 PM ISTCEO Doustdar is trying to restore investor confidence by sharpening Novo's focus, after a tough year in which the company issued multiple profit...
PE Giants Vie for Gland Pharma in USD 3 Billion Blockbuster Buyout Farhat Nasim13 Feb 2025 7:52 PM ISTFosun, which currently holds about a 51% stake in Gland Pharma, has appointed investment banks Morgan Stanley and UBS to facilitate the sale process.
Unexo Lifesciences Faces USFDA Heat Over Serious CGMP Violations Farhat Nasim22 Nov 2024 2:13 PM ISTIn response to the issues, the USFDA recommended a voluntary recall of all drug products manufactured at Unexo's facility for the U.S. market.
